IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Anlon Healthcare IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 121.03 Cr. The company is based in Rajkot and caters to Pharmaceutical sector. Interactive Financial Services is the merchant banker of Anlon Healthcare IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 20th February 2025.
Anlon Healthcare IPO posted revenues of ₹ 120.28 Cr. and PAT of ₹ 20.51 Cr. in FY25 on annualised basis.
Revenue:
₹ 120.28 Cr.
EBITDA Margin:
82.34
% 
Net Worth: ₹ 80.42 Cr.
Market Capitalisation:
₹ 483.68 Cr.
P/E:
23.57 times
P/BV: 2.40 times
EV/EBITDA: 5.46 times
Financial results of Anlon Healthcare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY25 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 181.29 | 128.00 | 111.55 | 84.97 | |
| Net Worth | 80.42 | 21.03 | 7.37 | 1.55 | |
| Total Debt | 58.34 | 74.56 | 66.39 | 60.32 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
120.28 | 66.58 | 112.88 | 57.14 | |
EBITDA
EBITDA on annualised basis |
99.04 | 15.57 | 12.66 | 5.81 | |
PAT
PAT on annualised basis |
20.51 | 9.66 | 5.82 | -0.11 | |
Anlon Healthcare IPO PAT Margin is 17.05 % , ROCE (Return on Capital Employed) is 21.93 % as per latest financial. The below table shows Anlon Healthcare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| EBITDA Margin (%) | 82.34 | 23.39 | 11.22 | 10.17 |
| PAT Margin (%) | 17.05 | 14.51 | 5.16 | -0.19 |
| EPS (₹) | 6.38 | 6.68 | 4.85 | -0.09 |
| ROE (%) | 25.50 | 45.93 | 78.97 | -7.10 |
| ROCE (%) | 21.93 | 16.29 | 17.16 | 9.38 |
| ROA (%) | 11.31 | 7.55 | 5.22 | -0.13 |
| Debt to Equity | 0.73 | 3.55 | 9.01 | 38.92 |
The market Capitalisation of Anlon Healthcare IPO is ₹ 483.68 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Anlon Healthcare IPO prospectus highlights an Return on Equity (ROE) of 25.50 % , Return on Assets (ROA) of 11.31 %, and an EBITDA Margin of 82.34 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Anlon Healthcare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Anlon Healthcare IPO is ₹ 483.68 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Anlon Healthcare IPO has a Price-to-Earnings (PE) ratio of 23.57 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Anlon Healthcare IPO reported revenue of ₹ 120.28 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Anlon Healthcare IPO provide insights into sales growth, market demand, and business scalability.
Anlon Healthcare recorded an EBITDA of ₹ 99.04 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Anlon Healthcare Profit After Tax (PAT) is ₹ 20.51 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 120.28 Cr.
EBITDA Margin:
82.34
%
Net Worth: ₹ 80.42 Cr.
Market Capitalisation:
483.68
P/E:
23.57 times
P/BV: 2.40 times
EV/EBITDA:
5.46
Anlon Healthcare operates in Pharmaceutical and Manufacturing Of High Purity Advance Pharmaceutical Intermediates (“Pharma Intermediate”) Which Serves As Raw Material/ Key Starting Material In The Manufacturing Of Active Pharmaceutical Ingredients. The Issue is listed on BSE,NSE in Sep, 2025. Anlon Healthcare IPO size was 121.03 with Issue price of 91.00 .
Merchant Banker(s) of Anlon Healthcare IPO: Interactive Financial Services Limited
Anlon Healthcare IPO subscription was 7.12 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Anlon Healthcare IPO listed at a listing price of 92.00 against the offer price of 91.00.
The current market price of Anlon Healthcare is 130.48.
Why Us?
